產品詳情
簡單介紹：
Anti-CRR9抗體產品質量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-CRR9抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-CRR9
Cat. Number:
Anti-CRR9抗體KL-6797R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Clefts of the oral-facial region usually occur in early fetal development and can affect the lip, the soft palate and the hard palate. Cleft lip (with or without cleft palate) is a genetically complex birth defect that occurs in approximately Anti-CRR9抗體one in every 750-1,000 live births. This is one of the most common birth defects and is multifactorial, with both genetic and environmental causes. Cleft lip- and palate-associated transmembrane protein 1 (CLPTM1) belongs to a family of cleft lip and palate transmembrane proteins. This family also contains cisplatin resistance-related protein (CRR9), which is involved in CDDP-induced apoptosis. CLPTM1L (cleft lip and palate transmembrane protein 1-like protein), also known as CRR9p (cisplatin resistance-related protein 9) is a 538 amino acid multi-pass membrane protein that belongs to the CLPTM1 family and, when overexpressed, enhances cisplatin-mediated apoptosis. CLPTM1L exists as two alternatively spliced isoforms encoded by a gene that maps to human chromosome 5p15.33.
Also known as:
Cisplatin resistance related Anti-CRR9抗體protein 9; Cisplatin resistance related protein CRR9p; Cisplatin resistance-related protein 9; Cleft lip and palate transmembrane protein 1 like protein; Cleft lip and palate transmembrane protein 1-like protein; CLP1L_HUMAN; CLPTM1 like; CLPTM1 like protein; CLPTM1-like protein; CLPTM1L; CRR9; CRR9p.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CLPTM1L/CRR9.
●
Predicted Molecular Weight: 62kDa.
Storage:
Shipped at 4℃, Store at -20℃ Anti-CRR9抗體(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions mustAnti-CRR9抗體 be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions mustAnti-CRR9抗體 be determined by the end user.
kl791Mu02 成纖維細胞生長因子受體1(FGFR1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor Receptor 1 (FGFR1)
kl791Ra01 成纖維細胞生長因子受體1(FGFR1)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor Receptor 1 (FGFR1)
kl792Mu02 S100鈣結合蛋白A8(S100A8)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A8 (S100A8)
kl793Mu02 S100鈣結合蛋白A9(S100A9)多克隆抗體 Polyclonal Antibody to S100 Calcium Binding Protein A9 (S100A9)
kl795Mu02 血清淀粉樣蛋白A2(SAA2)多克隆抗體 Polyclonal Antibody to Serum Amyloid A2 (SAA2)
kl797Mu01 成纖維細胞生長因子受體3(FGFR3)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)
kl797Mu02 成纖維細胞生長因子受體3(FGFR3)多克隆抗體 Polyclonal Antibody to Fibroblast Growth Factor Receptor 3 (FGFR3)
kl806Hu01 FK506結合蛋白12雷帕霉素關聯(lián)蛋白(FRAP)多克隆抗體 Polyclonal Antibody to FK506 Binding Protein 12 Raklycin Associated Protein (FRAP)
kl807Mu02 Jagged 1蛋白(JAG1)多克隆抗體 Polyclonal Antibody to Jagged 1 Protein (JAG1)
kl817Mu02 多功能蛋白聚糖(VS)多克隆抗體 Polyclonal Antibody to Versican (VS)
kl818Mu02 血管內皮生長因子受體1(VEGFR1)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
kl819Mu02 再生胰島衍生蛋白4(REG4)多克隆抗體 Polyclonal Antibody to Regenerating Islet Derived Protein 4 (REG4)
kl825Mu02 核因子κB2(NFκB2)多克隆抗體 Polyclonal Antibody to Nuclear Factor Kappa B2 (NFkB2)
kl827Ga01 軸突生長誘向因子1(Ntn1)多克隆抗體 Polyclonal Antibody to Netrin 1 (Ntn1)
